Now in its eleventh year, SAP-Centric EAM has become a go-to for the EAM community to stay current on innovative solutions and critical strategies for Enterprise Asset Management in conjunction with SAP PM. This year’s event features proven best practices that have been implemented at asset-intensive organizations across industries and functions.
With Americans spending billions of dollars each year on nutritional supplements, researchers have analyzed popular eye vitamins to determine whether their formulations and claims are consistent with scientific findings.
With 104 programs in late-stage clinical development, the stem cell therapy space could reach the commercialization threshold by 2017, but a number of challenges remain, according to research and consulting firm GlobalData.
An economist who advised the Obama administration on health care is apologizing to Congress for his "thoughtless" remarks that Republicans have seized upon in attacking the president's health law.
Merck remains committed to its $8.4 billion acquisition of Cubist Pharmaceuticals even though a federal court invalidated most of the company's patents protecting its top-selling antibiotic just hours after the deal was announced this week.
The SLR-1 and SLR-2 self-loading regulator valves have been improved and updated. The SLR-1 consists of a DA4 high-performance, pressure-loaded, flow-to-open pressure-reducing regulator with either a Cashco P1 or Fairchild Model 10 pressure-reducing regulator mounted onto it.
The stainless steel fermenter/bioreactor BIOSTAT® Cplus is designed for the cultivation of microorganisms and cell cultures. Typical fields of application include process development for the production of biopharmaceutics, vaccines, biofuels and secondary metabolites, the optimization of batch, fed-batch, continuous and perfusion processes as well as scale-up and scale-down experiments.
The debt-financed acquisition of Cubist Pharmaceuticals by Merck for $9.5 billion is the latest in a string of large, debt-financed acquisitions that are stressing the credit profiles of US healthcare companies, according to Fitch Ratings.
The Genesis 50L is an all-plastic bioprocess container designed to meet the ever evolving storage and shipping needs of the pharmaceutical industry.
Natrol has announced the completion of the sale of substantially all of the company’s assets to Aurobindo Pharma USA Inc., a manufacturer of generic pharmaceuticals and active pharmaceutical ingredients, for a purchase price of $132.5M plus assumed liabilities.
In 2011, Barry Nelson was diagnosed with lung cancer and told he had two years to live. Three years later, he's cancer-free thanks to an experimental immunotherapy drug and what he calls a relationship with God.
An Oregon woman who went to the hospital for an anxiety attack dies when administers incorrectly give her a paralyzing agent.
The review was requested by the school Senate last year in response to a decade-old controversy surrounding the death of Dan Markingson, who committed suicide while participating in an antipsychotic drug study at the University of Minnesota.
Is aspirin the wonder drug for everyone? A new study of healthy women finds the risks of taking low-dose aspirin may outweigh its value in preventing heart disease and cancer.